Leukemia

3 currently open clinical trials
Optimizing chemotherapy for the treatment of leukemia
GRAALL 2014
Treatment with ivosidenib or enasidenib for patients with mutations in enzymes (IDH1 or IDH2 mutation)
HOVON 150
Myelodysplastic syndromes: review of compliance with guidelines and their benefits for patients
SAKK 33/18
All cancer types